Technology: Ortho Dental Solution (ODS ) Ltd. is an emerging Israeli biotechnology company focusing on the development and commercialization of nitric oxide (NO) formulations for the treatment of oral cavity diseases.
In January 2011, ODS signed a licensing agreement with ENOX Inc, a Canadian biotech company, under which ENOX granted ODS the rights to use its patent application and knowhow in the field of NO for developing novel therapies for dental and gum diseases.
NO is a gas that is naturally produced by the body and plays a major role in innate immunity. It is a small, unstable gas molecule that acts as an anti-infective agent. ODS will use the unique NO formulation that has been proven to be an effective agent against a wide range of oral bacterial infections to develop novel products to reduce post dental treatment infections and to prevent periodontal disease.